Viamet Pharmaceuticals' Series C - II Round

Viamet Pharmaceuticals raised a round of funding on March 12, 2014.

Viamet Pharmaceuticals discovers and develops breakthrough therapies based on specialization in metalloenzyme chemistry and biology. The company's clinical portfolio includes novel agents to treat bot…

Articles about Viamet Pharmaceuticals' Series C - II Round: